Acalnib 100mg Capsules: Uses, Safety & Side Effects
Description
Acalnib 100mg Capsules contain acalabrutinib, a targeted cancer medicine belonging to the Bruton’s tyrosine kinase (BTK) inhibitor class. It is used under specialist supervision to treat certain types of blood cancers, including chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL) and mantle cell lymphoma (MCL), depending on the patient's condition and approved treatment indication.
Acalabrutinib works by blocking BTK, a protein involved in the growth and survival of certain B cells. This action can help control the progression of these cancers. Acalnib is a prescription medicine and should only be used following assessment by a qualified healthcare professional.
For patients and healthcare buyers in Singapore, the brand's registration status, authorised supply channel and product documentation should be verified before purchase or distribution.
Uses and Benefits of Acalnib 100mg Capsules
Acalnib 100mg Capsules may offer the following therapeutic benefits when appropriately prescribed:
Chronic Lymphocytic Leukaemia (CLL): Helps manage this type of blood cancer by targeting signalling pathways involved in cancer-cell survival.
Small Lymphocytic Lymphoma (SLL): May be prescribed to help control this related B-cell malignancy.
Mantle Cell Lymphoma (MCL): May be used in eligible patients according to the approved indication and treatment plan.
Targeted treatment approach: Inhibits BTK rather than acting as a conventional, broadly cytotoxic chemotherapy agent.
Oral administration: Provides a capsule-based treatment option for eligible patients, with dosing determined by their specialist.
Treatment response varies between individuals. Benefits depend on the cancer type, disease stage, previous treatment and overall health.
Acalnib 100mg Capsules Side Effects
Like other targeted cancer medicines, acalabrutinib may cause side effects. Commonly reported effects include:
Headache and fatigue
Nausea, diarrhoea or abdominal discomfort
Skin rash
Muscle or joint pain
Bruising or bleeding
Reduced blood-cell counts and increased susceptibility to infection
Important safety warning: Seek urgent medical attention for unusual or severe bleeding, black stools, blood in urine, fever, breathing difficulties, chest pain or a rapid or irregular heartbeat. Serious infections and heart rhythm problems can occur.
Inform your doctor about all medicines, supplements and herbal products you use. Grapefruit may interact with acalabrutinib. Do not start, stop or change treatment without medical advice. Follow the specific product leaflet for administration instructions.
Frequently Asked Questions (FAQs)
1. What is Acalnib 100mg used for?
It contains acalabrutinib, which may be prescribed for eligible patients with CLL, SLL or MCL, depending on the approved indication.
2. Is Acalnib 100mg a chemotherapy medicine?
It is a targeted therapy known as a BTK inhibitor. Although different from conventional chemotherapy, it can still cause significant adverse effects and requires medical monitoring.
3. Is Acalnib 100mg available in Singapore?
Availability and registration of the specific Acalnib brand must be verified. Consult Singapore's Health Sciences Authority (HSA) or National Drug Formulary and use authorised supply channels.
4. Can I take Acalnib 100mg without a prescription?
No. Acalabrutinib is a prescription-only cancer medicine that requires specialist supervision.
5. How should Acalnib 100mg be taken?
Follow your oncologist's instructions and the leaflet supplied with your specific product. Do not adjust your dose independently.
Important Medical Disclaimer
This page is for general educational purposes and does not replace professional medical advice. Acalnib 100mg should only be used when prescribed and supplied through legally authorised channels. Product registration, indications and availability should be confirmed for Singapore before publication or purchase.







